A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors., C R. Becerra, P Conkling, N Vogelzang, H Wu, S Hong, R Narwal, M Liang, F Tavakkoli, Naushira Pandya
Faculty Articles